GTX INC Collaboration Agreements
8 Contracts & Agreements
- Amendment #4 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated February 19, 2020 (Filed With SEC on August 6, 2020)
- Amendment #3 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated September 17, 2018 (Filed With SEC on April 8, 2019)
- Amendment #2 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated May 1, 2016 (Filed With SEC on April 8, 2019)
- Amendment #1 to Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated January 24, 2016 (Filed With SEC on April 8, 2019)
- Collaboration Agreement between Oncternal Therapeutics, Inc. and The University of Texas M.D. Anderson Cancer Center, dated December 15, 2014 (Filed With SEC on April 8, 2019)
- Ex-10.43 Exclusive License and Collaboration Agreement (Filed With SEC on March 11, 2008)
- Ex-10.37 Collaboration and License Agreement (Filed With SEC on November 3, 2006)
- Ex-10.24 Joint Collaboration & License Agreement (Filed With SEC on May 7, 2004)
